Korro Bio, Inc. (KRRO)
(Delayed Data from NSDQ)
$80.01 USD
+3.01 (3.91%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $80.08 +0.07 (0.09%) 7:26 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Korro Bio, Inc. (KRRO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$135.00 | $180.00 | $95.00 | 75.32% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Korro Bio, Inc. comes to $135.00. The forecasts range from a low of $95.00 to a high of $180.00. The average price target represents an increase of 75.32% from the last closing price of $77.00.
Analyst Price Targets (5 )
Broker Rating
Korro Bio, Inc. currently has an average brokerage recommendation (ABR) of 1.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.20 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, four are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 80% and 20% of all recommendations. A month ago, Strong Buy made up 80%, while Buy represented 20%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.20 | 1.20 | 1.20 | 1.20 | 1.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/19/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/14/2024 | William Blair | Myles R Minter | Not Available | Strong Buy |
8/14/2024 | H.C. Wainwright & Co. | Mitchell S Kapoor | Strong Buy | Strong Buy |
7/10/2024 | Piper Sandler | Yasmeen Rahimi | Strong Buy | Strong Buy |
3/26/2024 | BMO Capital Markets | Kostas Biliouris | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.20 |
ABR (Last week) | 1.20 |
# of Recs in ABR | 5 |
Average Target Price | $135.00 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 74 of 252 |
Current Quarter EPS Est: | -2.60 |
KRRO FAQs
Korro Bio, Inc. (KRRO) currently has an average brokerage recommendation (ABR) of 1.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Korro Bio, Inc. (KRRO) is $135.00. The current on short-term price targets is based on 3 reports.
The forecasts for Korro Bio, Inc. (KRRO) range from a low of $95 to a high of $180. The average price target represents a increase of $75.32 from the last closing price of $77.00.
The current UPSIDE for Korro Bio, Inc. (KRRO) is 75.32%
Based on short-term price targets offered by five analysts, the average price target for Korro Bio, Inc. comes to $135.00. The forecasts range from a low of $95.00 to a high of $180.00. The average price target represents an increase of 75.32% from the last closing price of $77.00.